PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied Materials
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied MaterialsView Video
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to mining
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to miningView Video

Latest Share Chat

Director/PDMR Shareholding

31 May 2016 18:11

RNS Number : 8052Z
Reckitt Benckiser Group PLC
31 May 2016
 

 

 

 

 

 

 

31 May 2016

 

 

RECKITT BENCKISER GROUP PLC

 DIRECTOR/PDMR SHAREHOLDING

 

Reckitt Benckiser Group plc (the "Company") announces the following changes in the interests of a Person Discharging Managerial Responsibility ("PDMR") in ordinary shares of 10 pence each in the share capital of the Company ("Shares").

 

On 27 May 2016, Rob de Groot, Area Executive Vice President ENA, a PDMR, exercised 61,693 share options granted on 8 December 2008 at an option price of £26.54 per share and disposed of all the resulting Shares at £69.00 per Share. On 31 May 2016, Mr de Groot exercised 50,000 options granted on 7 December 2009 at an option price of £30.78 per share and 111,048 options granted on 1 December 2010 at £33.68 per share and disposed of all the resulting Shares at £69.0141 and £69.0078 per share respectively.

 

Following these transactions, Rob de Groot's shareholding is 313,425 Shares, representing 0.0444% of the Company's issued share capital. Treasury shares have not been taken into account when calculating this percentage.

 

For further Information:Christine Logan

Company SecretaryTel +44 (0) 1753 217 800

 

About RB:

 

RB* is the world's leading consumer health and hygiene company. The company has operations in over 60 countries, with headquarters in London, Dubai and Amsterdam, and sales in most countries across the globe. The company employs approximately 37,000 people worldwide.

Inspired by a purpose to deliver innovative solutions for healthier lives and happier homes, RB is in the top 20 companies listed on the London Stock Exchange. We are the global No 1 or No 2 in the majority of our fast-growing categories, driven by an exceptional focus on innovation. Our health, hygiene and home portfolio is led by our global Powerbrands including Nurofen, Strepsils, Gaviscon, Mucinex, Durex, Scholl, Clearasil, Lysol, Dettol, Veet, Harpic, Cillit Bang, Mortein, Finish, Vanish, Calgon, Air Wick, Woolite and French's. Our Powerbrands represent 80% of net revenue.

 

RB is redefining the world of consumer health and hygiene. Our people and unique culture are at the heart of our success. We have a drive for achievement and a passion to outperform wherever we focus, including sustainability where we are targeting a 1/3 reduction in water impact, 1/3 reduction in carbon and 1/3 of net revenue from more sustainable products. We are proud to be Save the Children's largest global partner, with a new vision to radically reduce one of the world's largest killers of under 5s, diarrhoea.

 

For more information visit www.rb.com 

 

*RB is the trading name of the Reckitt Benckiser group of companies

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHBRGDUCGXBGLB

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.